2022
DOI: 10.1016/j.snb.2021.130914
|View full text |Cite
|
Sign up to set email alerts
|

Current and future prospective of biosensing molecules for point-of-care sensors for diabetes biomarker

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 231 publications
0
11
0
Order By: Relevance
“…The construction of a smartphone-based portable glucose monitoring system needs the advances in multiple fields. Firstly, the fabrication of a miniaturized glucose sensor requires the combination of technologies in related fields, such as biology, material science, analytical chemistry and mechanical technology [ 73 ]. Secondly, the design of the electrochemical testing circuit is to simplify the circuit integrated in the bulky electrochemical workstation, just leaving the module for the specific electrochemical glucose electrode [ 74 , 75 , 76 , 77 ].…”
Section: Smartphone-based Portable Glucose Monitoringmentioning
confidence: 99%
“…The construction of a smartphone-based portable glucose monitoring system needs the advances in multiple fields. Firstly, the fabrication of a miniaturized glucose sensor requires the combination of technologies in related fields, such as biology, material science, analytical chemistry and mechanical technology [ 73 ]. Secondly, the design of the electrochemical testing circuit is to simplify the circuit integrated in the bulky electrochemical workstation, just leaving the module for the specific electrochemical glucose electrode [ 74 , 75 , 76 , 77 ].…”
Section: Smartphone-based Portable Glucose Monitoringmentioning
confidence: 99%
“…The use of nanomaterials and microfluidics resulted in increased sensitivity of tests, holding a great promise as a future of more economical POC devices with even shorter turnaround time. A number of new highly pursued features of POC biosensors are being continuously developed and presented to the scientific community [ 194 ]. In a recently published review from Campuzano et al, the use of antibiofouling (antibiofouling polymers are being increasingly used in nanomedicine and macroscopic surface coatings, with poly(ethylene glycol) as the most widely-used polymer) [ 188 , 195 , 196 ], aptamer and biomolecular switches (molecular recognition receptors for electrochemical biosensors, with near real-time response) [ 188 , 197 ], next generation of amplification-free nucleic acid detection techniques (as an alternative to delicate and time-consuming rt-PCR, with immense importance in a resource-limited setting) [ 198 , 199 ] and other novel technologies are presented, with the main features that POC devices should comply with [ 188 ].…”
Section: Future Development and Outlookmentioning
confidence: 99%
“…Despite the relevance of GA as a glycemic biomarker, there are still no commercially available POC devices for its determination. Nevertheless, it is expected that due to its potential and the high incidence of T2DM, advances will be soon emerging [ 105 ]. The development of microfluidic platforms for GA determination has benefited from nanomaterials that eliminate the need for the use of chromogens and enzymes.…”
Section: Paper-based Point-of-care Platforms For Screening and Monitoring Of Type 2 Diabetes Mellitusmentioning
confidence: 99%
“…Despite the advances in these biomarkers, glucose continues to be one of the most studied as a model molecule for the development of sensors and POC devices. In addition, the devices for its determination are among the most advanced not only in the management of diabetes, but in general in the diagnostic area, it is also one of the only biomarkers with continuous monitoring devices clinically validated and available on the market [ 105 ].…”
Section: Paper-based Point-of-care Platforms For Screening and Monitoring Of Type 2 Diabetes Mellitusmentioning
confidence: 99%